Join Growin Stock Community!

艾訊3088.TW Overview

TW StockComputer & Periphera
(No presentation for 3088)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

艾訊（3088）Overall Performance

艾訊（3088）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

艾訊（3088） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

艾訊（3088）Key Information

艾訊（3088）Profile

Axiomtek Co., Ltd. designs, manufactures, and sells industrial computers and embedded platforms worldwide. The company offers boards and modules, such as industrial and embedded motherboards, system on modules, single board computers, add-on card and peripheral products, and smart display modules; and systems and platforms, including embedded systems, industrial PCs, machine vision products, edge AI GPU computing products, transportation systems, network communication platform, digital signage players, and medical-grade systems. It also provides industrial panel PCs which includes fanless touch panel PCs, touch panel PCs and monitors, medical computing products, transportation computing products, and interactive touchscreen kiosk; and artificial intelligence of things (AIoT) solutions comprising automation, autonomous mobile robots, as well as intelligent transportation, retail and hospitality, and medical products. The company's products are used in industrial automation, transportation, medical, edge artificial intelligence (Al), retail, power and energy, networking and communication, and gaming applications. Axiomtek Co., Ltd. was incorporated in 1990 and is headquartered in New Taipei City, Taiwan.

艾訊（3088）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
10.14
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
34.16%
Net Margin
7.14%
Revenue Growth (YoY)
1.82%
Profit Growth (YoY)
-5.58%
3-Year Revenue Growth
3.62%
3-Year Profit Growth
0.28%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
10.14
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
34.16%
Net Margin
7.14%
Revenue Growth (YoY)
1.82%
Profit Growth (YoY)
-5.58%
3-Year Revenue Growth
3.62%
3-Year Profit Growth
0.28%
default symbol

3088

艾訊

79.90D

-1.25%

(-0.01)

  • When is 3088's latest earnings report released?

    The most recent financial report for 艾訊 (3088) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3088's short-term business performance and financial health. For the latest updates on 3088's earnings releases, visit this page regularly.

  • Where does 3088 fall in the P/E River chart?

    According to historical valuation range analysis, 艾訊 (3088)'s current price-to-earnings (P/E) ratio is 12.74, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 3088?

    According to the latest financial report, 艾訊 (3088) reported an Operating Profit of 217.53M with an Operating Margin of 10.77% this period, representing a growth of 0.32% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 3088's revenue growth?

    In the latest financial report, 艾訊 (3088) announced revenue of 2.02B, with a Year-Over-Year growth rate of 3.44%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 3088 have?

    At the end of the period, 艾訊 (3088) held Total Cash and Cash Equivalents of 1.63B, accounting for 0.22 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 3088 go with three margins increasing?

    In the latest report, 艾訊 (3088) achieved the “three margins increasing” benchmark, with a gross margin of 33.38%%, operating margin of 10.77%%, and net margin of 10.35%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3088's profit trajectory and future growth potential.

  • Is 3088's EPS continuing to grow?

    According to the past four quarterly reports, 艾訊 (3088)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 1.93. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 3088?

    艾訊 (3088)'s Free Cash Flow (FCF) for the period is -61.44M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 80.63% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.